Updates
Termination of 62 Faculty Members: A Significant Move in Medical Education
A major administrative change has led to the provisional termination of 62 faculty members due to breaches of service and leave policies within the medical education sector.
Max Healthcare Invests Rs.1,000 Crore in New Pune Super Specialty Hospital
Discover Max Healthcare's ambitious plan for a state-of-the-art super specialty hospital in Pune, aimed at addressing the increasing healthcare needs driven by urban growth and a rising middle class.
Care Health Insurance Fined Rs 1 Crore by IRDAI for Claim Handling Lapses
Care Health Insurance faces a hefty fine from IRDAI for mishandling claims, violating policyholder rights and corporate governance rules. Penalties expand to include warnings on cybersecurity and accounting deficiencies.
Unlocking the Potential of Chronotherapy: Targeting Your Circadian Clock in Cancer Treatment
Discover how targeting the body's circadian clock can enhance cancer treatment through chronotherapy, aligning medication schedules with natural rhythms for optimal results.
Investment for Growth: Expanding into New Markets
Fueling Growth: Investment for Expansion into New Markets and Operational Strength
Addressing Trademark Loopholes in Pharma: Insights from ETHealthworld NutriWell Conclave
Exploring Solutions to Drug Mislabeling and Exploitation in the Pharma Industry
Comprehensive Growth Analysis of CGHS Hospital Empanelment (2021-2022)
Discover the steady growth trajectory of CGHS hospital empanelment over 2021-2022, showcasing not only an increase in the number of empanelled hospitals but also a noteworthy churn rate. Stay informed on healthcare dynamics!
IHH's Strategic Shareholding in Fortis Healthcare and Malar Hospitals
Discover IHH's stakes in Fortis Healthcare and Malar Hospitals, now at 31.17% and 62.73%, respectively, following their recent open offer. Explore how these investments shape the healthcare landscape and IHH's strategic ambitions.
Reliance Expands into Healthcare with Strand Life Sciences Acquisition
Reliance's latest move into specialized healthcare diagnostics, powered by its acquisition of Strand Life Sciences in 2021, aims to enhance genomic sciences and innovative technologies, promising significant advancements in the sector.
The Rise of Weight-Loss Drugs: Insights from the ETHealthworld NutriWell Conclave
Exploring the surge in weight-loss drugs and ensuring patient safety in India.
Intermittent PARP Inhibitor Trial for Ovarian Cancer: IPIROC Study
Discover the IPIROC trial, testing an innovative dosing strategy of rucaparib for ovarian cancer. This study aims to minimize side effects and costs while maintaining efficacy in patients.
Round 2 Seat Allotment Results: Key Details You Need to Know
Stay Updated on Round 2 Seat Allotment Results: Essential Dates and Instructions
